The strong active-manager accumulation suggests a catalyst-driven thesis (likely pipeline progress or margin expansion in the generics business). Monitor for upcoming earnings or FDA decisions that could validate the cluster's conviction. The lack of insider buying is a caution flag — consider waiting for insider confirmation before adding to positions.
Executive Summary
A strong institutional accumulation cluster emerged in Amneal Pharmaceuticals during 2026-Q2, with 14 buyers adding a net $53.2M in new positions versus only 2 sellers trimming $4.7M. The buying is dominated by active asset managers (Congress Asset Management, Pictet, Exchange Traded Concepts, Jennison) and quant fund Citadel, suggesting a shared thesis around the company's generic and specialty pharmaceutical pipeline. The cluster's conviction is amplified by the cross-filing actuarial verdict (inst-earnings-context + inst-offering-context as an amplifier), though the lack of insider open-market buying (confluence score 21/100, divergent) tempers the signal somewhat.
Key Financial Metrics
Institutional Positions
Net institutional flow: $48.5M
▲ Buyers (14)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Congress Asset Management | NEW | — | $13.5M | $13.5M |
| Citadel | ADD | +93.7% | $19.4M | $12.2M |
| Pictet Asset Management Holding | DOUBLED | +2032.9% | $10.6M | $10.2M |
| Wells Fargo | DOUBLED | +301.8% | $7.3M | $6.0M |
| Exchange Traded Concepts | DOUBLED | +6017.8% | $6.3M | $6.3M |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| UBS | TRIM | -47.2% | $10.5M | -$2.8M |
| RenTech | TRIM | -68.4% | $3.4M | -$1.9M |
Key Facts
- 14 institutional buyers added a net $53.2M in AMRX during 2026-Q2, while only 2 sellers trimmed $4.7M
- Congress Asset Management initiated a new $13.5M position (782.8K shares), the largest single new stake
- Pictet Asset Management nearly doubled its position, adding $10.2M to reach $10.6M total
- Citadel added $12.2M, increasing its stake by 93.7% to $19.4M
- Wells Fargo more than tripled its position, adding $6.0M to reach $7.3M
- The two sellers were UBS (trimmed $2.8M) and Renaissance Technologies (trimmed $1.9M)
- No open-market insider buying accompanied the institutional cluster, creating a divergent signal
Financial Impact
14 institutions accumulated $53.2M in new AMRX positions while 2 reduced holdings by $4.7M, for a net inflow of approximately $48.5M
Risk Factors
- 45-day 13F reporting lag means positions may have been partially or fully unwound by now
- No insider open-market buying to corroborate the institutional thesis
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-AMRX-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K/A | $21.02 | awaiting T+60 | — | — |
Sep 18, 2026 5w ago | Press Release | $20.16 | awaiting T+60 | — | — |
Aug 16, 2026 10w ago | Institutional Cluster | $18.42 | awaiting T+60 | — | — |
Aug 14, 2026 10w ago | Insider Cluster | $18.42 | awaiting T+60 | — | — |
Aug 13, 2026 10w ago | Insider Cluster | $18.15 | awaiting T+60 | — | — |
Aug 10, 2026 11w ago | 8-K | $17.10 | awaiting T+60 | — | — |
Jul 30, 2026 12w ago | DEFA14A | $18.50 $20.38 | ▲ +10.16% | ▲ +7.70% | — |
Jul 17, 2026 14w ago | Press Release | $17.85 $20.03 | ▲ +12.21% | ▲ +7.53% | — |
Jun 29, 2026 17w ago | DEFM14A | $17.29 $19.50 | ▲ +12.78% | ▲ +8.40% | — |
Jun 29, 2026 17w ago | Press Release | $17.29 $19.50 | ▲ +12.78% | ▲ +8.40% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers